An interventional study of Auto-aligned OCT in Eye Diseases, Retinal Disease and Glaucoma, sponsored by Duke University. Recruiting at 1 site in United States. Open to participants aged 1 Month and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-25.
Sponsored by Duke University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adult volunteers, and adult and pediatric patients in clinic.
Handheld OCT imaging is an advancement in ophthalmic imaging technology allowing us to image the pediatric retina. lt has tremendous potential to be applied to assess the structure and blood flow of children with retinal vascular diseases or as a screening tool for pediatric retinal diseases. Despite progress in the development of hand-held OCT probes, there remains a critical gap in technology to achieve fast, proper alignment between the imaging device and the infant eye. Even with the most skilled operators, to acquire consistent OCT and OCTA data capture for longitudinal follow up in uncooperative patients at the bedside remains difficult. lmprovements in hand-held OCT probe technology for auto-alignment to the patient's eye, as well as on-line detection of image quality and auto-saving at the proper time, would address this critical gap in handheld OCT technology. Our biomedical engineering team, has developed prior iterations of the handheld OCT devices and successfully imaged the pediatric retina. The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adult volunteers, and adult and pediatric patients in clinic.
The investigators plan to enroll 20 healthy adult volunteers, 20 adult patients and 10 pediatric patients from the ophthalmology clinic. This is an observational study. There are no known risks associated with handheld OCT imaging and no adverse events identified imaging with prior iterations of handheld OCT devices. lmaging data will be downloaded to a secure server for protocol image processing, segmentation, and analysis per protocol in the Duke Advanced Research in SS/SDOCT lmaging (DARSI) laboratory.
389 studies on the registry are indexed under Eye Diseases; 62 are open to participants now.
This study's planned enrollment of 50 is below the median of 62 across 269 interventional studies indexed under Eye Diseases.
Browse Eye Diseases studies →Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Healthy adult volunteers recruited from the patient population, students or employees of Duke University or Duke Eye Center (n=20)
Device: Auto-aligned OCT
Adult participants recruited from the patient population of Duke Eye Center undergoing clinical examination (n=20)
Device: Auto-aligned OCT
Minor participants recruited from the patient population of Duke Eye Center undergoing clinical examination (n=10)
Device: Auto-aligned OCT
Swept Source OCT system with improved hand-held probe technology for auto-alignment to the patient's eye, as well as on-line detection of image quality and auto-saving at the proper time
Number of participants with abnormal retinal microanatomy
Measured by optical coherence tomography (OCT) reading.
Time frame: Up to 4 single imaging sessions at clinical visits over 2 years
Severity of abnormal retinal microanatomy
Measured by optical coherence tomography (OCT) reading.
Time frame: Up to 4 single imaging sessions at clinical visits over 2 years
Retinal thickness (microns) at the fovea and surrounding optic nerve as measured by OCT analysis
Measured by optical coherence tomography (OCT) analysis.
Time frame: Up to 4 single imaging sessions at clinical visits over 2 years
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Mar 2027, 12 months after the start.
Of 49 non-industry interventional studies with no phase under Eye Diseases, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 45. This study's planned 12 months is below that.
Counting every sponsor, half of 68 studies reached it within 24 months; a quarter within 9 and three quarters within 49.
Eye Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.